Reducing prostate cancer racial disparity: evidence for aggressive early prostate cancer PSA testing of African American men.

Racial Differences in the Diagnosis and Treatment of Prostate Cancer. Int Neurourol J (2016) 0.84

Proteomic Profiling of Serum-Derived Exosomes from Ethnically Diverse Prostate Cancer Patients. Cancer Invest (2015) 0.82

Prostate cancer in men of African origin. Nat Rev Urol (2015) 0.81

Molecular mechanisms of curcumin and its semisynthetic analogues in prostate cancer prevention and treatment. Life Sci (2016) 0.81

Immunoseroproteomic Profiling in African American Men with Prostate Cancer: Evidence for an Autoantibody Response to Glycolysis and Plasminogen-Associated Proteins. Mol Cell Proteomics (2016) 0.76

Is prostate cancer different in black men? Answers from 3 natural history models. Cancer (2017) 0.75

Is prostate cancer stage migration continuing for black men in the PSA era? Prostate Cancer Prostatic Dis (2017) 0.75

Racial differences in prostate cancer risk in young HIV-positive and HIV-negative men: a prospective cohort study. Cancer Causes Control (2017) 0.75

The impact of sociodemographic factors and PSA screening among low-income Black and White men: data from the Southern Community Cohort Study. Prostate Cancer Prostatic Dis (2017) 0.75

African-American Prostate Cancer Disparities. Curr Urol Rep (2017) 0.75

Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72

Cancer statistics, 2014. CA Cancer J Clin (2014) 72.81

Mortality results from a randomized prostate-cancer screening trial. N Engl J Med (2009) 30.05

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 15.83

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial. Lancet Oncol (2010) 12.64

Early detection of prostate cancer: AUA Guideline. J Urol (2013) 9.14

African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them? J Clin Oncol (2013) 4.20

Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity. J Urol (2010) 3.70

Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC). Eur Urol (2009) 3.42

Clinical and demographic characteristics associated with prostate cancer progression in patients on active surveillance. J Urol (2012) 2.70

Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Clin Trials (2010) 2.38

Re: Early detection of prostate cancer: AUA guideline: H. B. Carter, P. C. Albertsen, M. J. Barry, R. Etzioni, S. J. Freedland, K. L. Greene, L. Holmberg, P. Kantoff, B. R. Konety, M. H. Murad, D. F. Penson and A. L. Zietman J Urol 2013; 190: 419-426. J Urol (2013) 1.75

Improved overall survival trends of men with newly diagnosed M1 prostate cancer: a SWOG phase III trial experience (S8494, S8894 and S9346). J Urol (2012) 1.65

Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival. J Clin Oncol (2010) 1.37

Genes associated with prostate cancer are differentially expressed in African American and European American men. Cancer Epidemiol Biomarkers Prev (2013) 1.32

Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma. J Urol (2009) 1.22

Should African-American men be tested for prostate carcinoma at an earlier age than white men? Cancer (1999) 0.93

Adenocarcinoma of the prostate: an expensive way to die. Prostate Cancer Prostatic Dis (2002) 0.90

Disparities in prostate cancer in African American men: what primary care physicians can do. Cleve Clin J Med (2012) 0.87